The outbreak of COVID-19 had researchers around the world using genomics to understand its spread and evolution, discovering vital clues that helped to inform public health decision-making and the development of new diagnostics, therapeutics, and vaccines. As Covid genomics work exploded, the once hefty prices sharply dropped, and sequencing could be done quicker than ever before. The combination of the lower cost and the increased speed sequences make genomic sequencing more feasible for other areas of research. Leveraging its global panel, SurveyHealthcareGlobus (SHG) surveyed an equal mix of 350 PCP/FPs and oncologists in six countries to gain their insights on how whole genome sequencing will impact the future of healthcare and medicine in their specialties. SHG’s webinar, The Future of Genomics in Healthcare and Medicine covers findings from this research, examining respondent perspectives as they share their experiences and opinions. Please join SHG’s Tamara Burke, Director, Qualitative Business Development, and John Turner, Senior VP, Client Relationships on October 6, 2021, at 1: 00 p.m. ET.

You will learn:

• Physician’s current and expected futures use of genomic sequencing
• The impact of genome sequencing on individual healthcare
• Views on how genome sequencing will change the practice of medicine
• Perspectives on physicians’ concerns about genome sequencing for their patients
• How genome sequencing is changing cancer treatment plans